Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

Recent & Breaking News (TSXV:THRM)

Therma Bright Announces EU-CE Approval for AcuVid COVID-19 Rapid Antigen Saliva Test

John Ballem  April 19, 2021

Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits

Newsfile April 19, 2021

Therma Bright Provides Update on Brazilian Performance Study of its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Newsfile April 13, 2021

Therma Bright’s (TSXV:THRM) Brazilian performance study of its AcuVid™ COVID-19 Rapid Saliva-Based Antigen Test is complete

Brieanna McCutcheon  April 13, 2021

Therma Bright (TSXV:THRM) applies to Health Canada for clinical study of COVID-19 saliva test

Trevor Abes  March 25, 2021

Therma Bright Secures IRB Approval for COVID-19 Saliva-Based Test Study

Stockhouse Editorial March 25, 2021

Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Newsfile March 25, 2021

Therma Bright (TSXV:THRM) partners with Ridge Global to expand its U.S. and global reach

Brieanna McCutcheon  March 24, 2021

Therma Bright Partners with Ridge Global to Expand Its United States and Global Reach

Newsfile March 24, 2021

Therma Bright Begins Clinical Study Rapid for COVID-19 Antigen Test

Stockhouse Editorial March 19, 2021

Therma Bright (TSXV:THRM) begins clinical study for rapid COVID-19 antigen test

Trevor Abes  March 18, 2021

Life After the Pandemic: Rapid Saliva Testing for COVID-19

Fraser Palamara March 18, 2021

Therma Bright Initiates Clinical Performance Study in Brazil for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Newsfile March 18, 2021

Therma Bright (TSXV:THRM) submits COVID-19 antigen test for approval

Simon Druker  March 11, 2021

Therma Bright Submits Application to Research Ethics Board for Approval of Clinical Trials for AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Newsfile March 11, 2021

Therma Bright enters into clinical trial agreement for its AcuVid COVID-19 rapid antigen test

John Ballem  February 26, 2021

IIROC Trading Resumption - THRM

Canada NewsWire February 26, 2021

Therma Bright Enters into Clinical Trial Agreement for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Newsfile February 26, 2021

IIROC Trading Halt - THRM

Canada NewsWire February 26, 2021

Therma Bright (TSXV: THRM) has added C$1,171,875 to its treasury

John Ballem  January 29, 2021